Last updated: June 19, 2016
Sponsor: Lamis Kaddam
Overall Status: Trial Status Unknown
Phase
2
Condition
Arthritis And Arthritic Pain
Rheumatoid Arthritis
Musculoskeletal Diseases
Treatment
N/AClinical Study ID
NCT02804581
University of Khartoum
Ages 20-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Clinical diagnosis of Rheumatoid Arthritis
Clinically stable as evidenced by medical history, complete physical examination
All medications and dosages are stable for 6 weeks before study entry,
Non Pregnant ladies.
Exclusion
Exclusion Criteria:
- 1- hepatic, cardiovascular, pulmonary, malignant, hematologic, neurologic, infectious,or inflammatory diseases unrelated to Rheumatoid arthritis.
2-Hospital admission within 4 weeks of start of the study.
3- Uncontrolled hypertension 4- Asthma or severe atopic disease;
Study Design
Total Participants: 45
Study Start date:
June 01, 2016
Estimated Completion Date:
October 31, 2016
Study Description
Connect with a study center
Military Hospital Rheumatology
Khartoum, Umdorman 1121
SudanActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.